Patents by Inventor Stanislas Mayer

Stanislas Mayer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NEW ADENOSINE RECEPTOR LIGANDS AND USES THEREOF
    Publication number: 20110288074
    Abstract: The present invention provides new compounds with high affinity for adenosine A2A receptors. It also provides antagonists of adenosine A2A receptors and their use as medicaments for the treatment and/or prophylaxis of diseases and disorders where the partial or total inactivation of adenosine A2A receptors signalling pathways could be beneficial such as Alzheimer's disease, Parkinson's disease, attention deficit and hyperactivity disorders (ADHD), Huntington's disease, neuroprotection, schizophrenia, anxiety and pain.
    Type: Application
    Filed: January 25, 2010
    Publication date: November 24, 2011
    Applicant: DOMAIN THERAPEUTICS
    Inventors: Stephan Schann, Stanislas Mayer
  • PYRROLO[1,2-A]QUINOXALINE DERIVATIVES AS ADENOSINE A3 RECEPTOR MODULATORS AND USES THEREOF
    Publication number: 20090093476
    Abstract: The present invention provides new compounds displaying high affinity for adenosine A3 receptors. It also provides modulators of adenosine A3 receptors. It further provides compounds for the treatment and/or prophylaxis of conditions and diseases where adenosine A3 receptor plays a role. Pharmaceutical compositions for the treatment and/or prophylaxis of conditions and diseases where adenosine A3 receptors play a role are also described.
    Type: Application
    Filed: December 19, 2006
    Publication date: April 9, 2009
    Applicant: FAUST PHARMACEUTICALS
    Inventors: Stephan Schann, Stanislas Mayer, Sophie Gardan
  • Partial and full agonists of A1 adenosine receptors
    Patent number: 7300923
    Abstract: Disclosed are syntheses suitable for large scale manufacture of novel compounds that are partial and full A1 adenosine receptor agonists, useful for treating various disease states, in particular tachycardia and atrial flutter, angina, and myocardial infarction.
    Type: Grant
    Filed: August 29, 2005
    Date of Patent: November 27, 2007
    Assignee: CV Therapeutics, Inc.
    Inventors: Jeff Zablocki, Elfatih Elzein, Michael Organ, Yaroslav Bilokin, Stanislas Mayer, Anthony Disanti, Scott Miller, Peter Kernast
  • Partial and full agonists of A1 adenosine receptors
    Publication number: 20060052330
    Abstract: Disclosed are syntheses suitable for large scale manufacture of novel compounds that are partial and full A1 adenosine receptor agonists, useful for treating various disease states, in particular tachycardia and atrial flutter, angina, and myocardial infarction.
    Type: Application
    Filed: August 29, 2005
    Publication date: March 9, 2006
    Inventors: Jeff Zablocki, Elfatih Elzein, Michael Organ, Yaroslav Bilokin, Stanislas Mayer, Anthony Disanti, Scott Miller, Peter Kernast